|
Today
ten million people are at risk of Sudden Cardiac Death. Of
that huge group over 400,000 will die from SCD this year,
many of them without any warning.
The delivering the most appropriate care for each cardiac
patient at risk for Sudden Cardiac Death required the healthcare
provider be able to determine who is likely to benefit from
ICD therapy from patients not likely to benefit from ICD
therapy. At Cambridge Heart, we offer a simple solution to
this challenge. Our Microvolt T-Wave Alternans test which
utilizes the proprietary Analytic Spectral Method is a non-invasive,
easy to perform diagnostic test clinically proven to identify
patients at risk of Sudden Cardiac Death.
References
|
.gif){kind=small}
